Skip to content

R350 IPN913606Recalls & reported problems

Teleflex Incorporated · R350 V2 Guidewire · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10841156101176), received between Dec 29, 2020 and Mar 5, 2021 — classified as 1 death, 1 injury.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Use of Device Problem1

Patient problems

  • Hematoma1
  • Perforation1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 5, 2021Use of Device Problem; Use of Device Problem

    AS REPORTED: DURING A STUDY CASE, FOLLOWING RETROGRADE CTO PCI OF THE RCA, PATIENT DEVELOPED A SMALL INTRASEPTAL HEMATOMA WHICH WAS NOTED ON ANGIOGRAPHY BUT NOT VIA ECHOCARDIOGRAM. TREATED WITH TWO INTRACORONARY COILS WITH DECREASE FLOW NOTED. PATIENT WAS OBSERVED IN THE CATH LAB FOR AN ADDITIONAL 20 MIN. POST-COIL DEPLOYMENT WITH REPEAT ANGIOGRAPHY SHOWING NO FURTHER ENLARGEMENT OF THE HEMATOMA. SITE STATES THAT THE CAUSE OF THE HEMATOMA WAS DUE TO THE R350 EXTERNALIZATION GUIDEWIRE (STUDY DEVICE) BEING REMOVED FROM SEPTAL TOO QUICKLY.

    Patient problems: Hematoma

    MAUDE report 11424002 ↗
  • DeathDec 29, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    SUBJECT EXPIRED POST INDEX PROCEDURE IN THE CTO PCI STUDY IN WHICH NUMEROUS DEVICES WERE USED. AT THE END OF THE INDEX PROCEDURE A PERFORATION WAS NOTED WHICH WAS TREATED WITH A COVERED STENT. ECHOCARDIOGRAM SHOWED STABLE PERICARDIAL EFFUSION W/O TAMPONADE. DURING EVENING POST-PROCEDURE SUBJECT WAS ON BEDSIDE COMMODE C/O NAUSEA WAS GIVEN A BASIN FOR EMESIS, HOWEVER HE COLLAPSED WAS BROUGHT BACK TO BED WHERE HE WAS FOUND PULSELESS. CPR AND ACLS PROTOCOLS WERE INITIATED. BEDSIDE CANNULATION OF VA ECMO CIRCUIT W/ PERFUSION AND TVP WAS PLACED. BEDSIDE TEE DEMONSTRATED STABLE PERICARDIAL EFFUSION W/O EVIDENCE OF TAMPONADE. SUBJECT WAS EMERGENTLY BROUGHT DOWN TO CATH LAB FOR CORONARY REPERFUSION. LMCA, LAD LCX OM1 AND OM2 THROMBOSED, S/P PTCA AND ASPIRATION THROMBECTOMY RESTORED TIMI3 FLOW TO LMCA, PROX LAD, LCX, OM1 AND OM2, NO FLOW TO DISTAL LAD DESPITE THROMBECTOMY, PTCA AND VASODILATOR PHARMACOTHERAPY. UPON RETURN FROM CATH LAB PATIENT CONTINUED TO DETERIORATE. SUBJECT SHOWED SIGNS OF HEPATIC AND RENAL FAILURE REQUIRING SLED. 4U PRBC FOR SIGNIFICANT ANEMIA WAS GIVEN (HGB 6.1 WITH MINIMAL IMPROVEMENT AFTER TRANSFUSION). VA ECMO RPM WAS INCREASED TO 4000 WITH IMPROVEMENT IN FLOWS (3.4-

    Patient problems: Perforation

    MAUDE report 11088581 ↗

Other Wire, guide, catheter devices

All Wire, guide, catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page